Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

BCL-2 Inhibition in AML: High Effectiveness of Combination Therapy - Overview of Trials Combining Venetoclax and Targeted Agents (IDH, FLT3, MDM2 Inhibitors)

0 views
November 5, 2019
Comments 0
Login to view comments. Click here to Login